XML 69 R54.htm IDEA: XBRL DOCUMENT v3.21.2
Share-Based Compensation Share-Based Compensation (Details) - USD ($)
3 Months Ended 6 Months Ended
Sep. 30, 2021
Sep. 30, 2021
Sep. 30, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Item]      
Remaining shares available for grant 3,257,138 3,257,138  
Weighted-average assumptions used for options granted:      
Risk-free interest rate   1.16% 0.46%
Expected life of options   5 years 10 months 24 days 6 years
Exptected dividend yield of stock   0.97% 0.96%
Expected volatility of stock   24.37% 23.04%
Estimated forfeiture rate   2.85% 2.78%
Summary of share option activity:      
Outstanding at March 31, 2017   1,637,047  
Granted   214,734  
Exercised   (112,199)  
Forfeited   0  
Outstanding at June 30, 2017 1,739,582 1,739,582  
Exercisable at June 30, 2017 1,094,684 1,094,684  
Weighted average exercise price:      
Outstanding at March 31, 2017   $ 112.03  
Granted   210.79  
Exercised   68.78  
Forfeited   0  
Outstanding at June 30, 2017 $ 127.01 127.01  
Exercisable at June 30, 2017 $ 99.58 $ 99.58  
Average Remaining Contractual Term, Outstanding at June 30, 2017   6 years 8 months 12 days  
Aggregate Intrinsic Value, Outstanding at June 30, 2017 $ 135,815,000 $ 135,815,000  
Average Remaining Contractual Term, Exercisable at June 30, 2017   5 years 8 months 12 days  
Aggregate Intrinsic Value, Exercisable at June 30, 2017 $ 114,798,000 $ 114,798,000  
Non-vested stock options outstanding expected to vest 626,598 626,598  
Ordinary shares, closing price $ 204.28 $ 204.28  
Total intrinsic value of stock options exercised   $ 16,076,000 $ 25,244,000
Net cash proceeds from the exercise of stock options   $ 7,829,000 $ 20,600,000
Weighted average grant date fair value of stock option grants, per share   $ 37.34 $ 27.66
Summary of non-vested restricted share activity:      
Unrecognized compensation cost related to nonvested share-based compensation granted $ 61,084,000 $ 61,084,000  
Weighted Average Period For Total Compensation Expense Not Yet Recognized   2 years 2 months 12 days  
Stock Appreciation Rights (SARs) [Member]      
Weighted average exercise price:      
FairValueOfOutstandingStockAppreciationRights     $ 448,000
Restricted Stock      
Summary of non-vested restricted share activity:      
Number of Restricted Shares, Non-vested at Beginning of Period   533,323  
Weighted-Average Grant Date Fair Value, Non-vested at Beginning of Period   $ 121.35  
Number of Restricted Shares, Granted   112,036  
Weighted-Average Grant Date Fair Value, Granted   $ 192.85  
Number of Restricted Shares, Vested   (170,619)  
Weighted-Average Grant Date Fair Value, Vested   $ 96.19  
Number of Restricted Shares, Canceled   (8,425)  
Weighted-Average Grant Date Fair Value, Canceled   $ 153.97  
Number of Restricted Shares, Non-vested at End of Period 466,315 466,315  
Weighted-Average Grant Date Fair Value, Non-vested at End of Period $ 148.57 $ 148.57  
Fair Value, Share-based Payment Awards, Other than Options   $ 17,865,000  
Restricted Stock Units (RSUs)      
Weighted average exercise price:      
Weighted average grant date fair value of stock option grants, per share $ 191.18    
Summary of non-vested restricted share activity:      
Number of Restricted Shares, Non-vested at Beginning of Period   29,500  
Number of Restricted Shares, Granted   14,189  
Number of Restricted Shares, Vested   (15,534)  
Number of Restricted Shares, Canceled   (430)  
Number of Restricted Shares, Non-vested at End of Period 27,725 27,725  
Share-based Payment Arrangement, Expense   $ 17,985,000  
Restricted Stock or Unit Expense   $ 280,402  
Share-based Compensation Arrangement by Share-based Payment Award, Conversion Ratio   0.4262  
Share-based Compensation Arrangement by Share-based Payment Award, Grants in Period, Weighted Average Grant Date Fair Value Attributable to Pre-Acquisition Services $ 18,173,000    
Share-based Compensation Arrangement by Share-based Payment Award, Grants in Period, Weighted Average Grant Date Fair Value $ 53,607,000    
RSUs Cantel      
Summary of non-vested restricted share activity:      
Number of Restricted Shares, Non-vested at Beginning of Period   0  
Weighted-Average Grant Date Fair Value, Non-vested at Beginning of Period   $ 0  
Number of Restricted Shares, Granted   280,402  
Weighted-Average Grant Date Fair Value, Granted   $ 191.18  
Number of Restricted Shares, Vested   (157,821)  
Weighted-Average Grant Date Fair Value, Vested   $ 191.18  
Number of Restricted Shares, Canceled   (3,380)  
Weighted-Average Grant Date Fair Value, Canceled   $ 191.18  
Number of Restricted Shares, Non-vested at End of Period 119,201 119,201  
Weighted-Average Grant Date Fair Value, Non-vested at End of Period $ 191.18 $ 191.18  
Unrecognized compensation cost related to nonvested share-based compensation granted $ 12,521,000 $ 12,521,000